Company dossier
Onesource Specialty Pharma
NSE:ONESOURCE · ISIN INE013P01021
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Onesource Specialty Pharma
Financials
Structured filings
Exchange XBRLReported financial periods
| Metric | Quarter · 31 Dec 24 | Quarter · 30 Sept 24 |
|---|---|---|
| Revenue | ₹392.6 Cr | ₹68 Cr |
| Profit before tax | ₹-66.5 Cr | ₹-39.1 Cr |
| Profit after tax | ₹-68.8 Cr | ₹-39.3 Cr |
| Finance cost | ₹45.8 Cr | ₹20.7 Cr |
| Impairment | N/A | N/A |
| EPS | ₹-6.31 | ₹-9.41 |
Accounting lens
Research frameworkWhat deserves analyst attention
Confirm quarterly, year-to-date and annual periods before calculating growth. The table preserves the exchange period labels.
Treat scope changes as breaks in comparability and open the linked XBRL before relying on a trend.
Sector metrics and accounting choices require additional facts beyond this common cross-company layer.